Finance

Lists
9572:TADAWUL
Al-Razi Medical Company SJSC
SAR 23,00
-1,58%
(-0,37) 1D
15 Okt., 15:00:00 GMT+3  ·   SAR
All symbols
SymbolPriceChange% Change
Generating top insights for 9572...
Open
SAR 23,00
High
SAR 23,00
Low
SAR 23,00
Mkt. cap
34,96 m
Avg. vol.
8,65 k
Volume
1,43 k
P/E ratio
31,15
52-wk high
SAR 39,36
52-wk low
SAR 22,29
EPS
SAR 0,74
Shares outstanding
598,60 k
No. of employees
123
Open
SAR 23,00
High
SAR 23,00
Low
SAR 23,00
Mkt. cap
34,96 m
Avg. vol.
8,65 k
Volume
1,43 k
P/E ratio
31,15
52-wk high
SAR 39,36
52-wk low
SAR 22,29
EPS
SAR 0,74
Shares outstanding
598,60 k
No. of employees
123
News stories
From web sources and news partners
About Al-Razi Medical Company SJSC
CEO-
Employees123
Founded1986
Headquarters-
SectorDrug
Previous reportsAll values in SAR
Loading Previous Earnings...
Revenue
Net income
All values in SAR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
20,20 m
20,20 m
18,00 m
18,00 m
Cost of goods sold
15,18 m
15,18 m
13,14 m
13,14 m
Cost of revenue
15,18 m
15,18 m
13,14 m
13,14 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,56 m
4,56 m
4,49 m
4,49 m
Operating expense
4,56 m
4,56 m
4,49 m
4,49 m
Total operating expenses
19,74 m
19,74 m
17,62 m
17,62 m
Operating income
457,26 k
457,26 k
374,95 k
374,95 k
Other non operating income
120,22 k
120,22 k
91,58 k
91,58 k
EBT including unusual items
391,28 k
391,28 k
276,97 k
276,97 k
EBT excluding unusual items
388,26 k
388,26 k
276,97 k
276,97 k
Income tax expense
39,53 k
39,53 k
67,50 k
67,50 k
Effective tax rate
10,10%
10,10%
24,37%
24,37%
Other operating expenses
-
-
-
-
Net income
351,75 k
351,75 k
209,47 k
209,47 k
Net profit margin
1,74%
1,74%
1,16%
1,16%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-189,22 k
-189,22 k
-189,55 k
-189,55 k
Net interest expenses
-189,22 k
-189,22 k
-189,55 k
-189,55 k
Depreciation and amortization charges
-
-
-
-
EBITDA
895,62 k
895,62 k
810,76 k
810,76 k
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme